AVXL · Anavex Life Sciences Corp. · Documents
$1.33
-0.03 (-2.21%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$120.97M
Shares
92.70M
Volume · Oct 23
627.22K
Avg daily vol (3M)
1.03M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| S-3 | — | 2024-07-29 | — | |
| 8-K | — | 2024-06-21 | 2024-06-18 | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| DEF 14A | — | 2024-05-06 | — | |
| DEFA14A | — | 2024-05-06 | — | |
| 10-Q | — | 2024-02-07 | 2023-12-31 | |
| 10-K | — | 2023-11-27 | 2023-09-30 | |
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-05-24 | 2023-05-23 | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| 8-K | — | 2023-04-14 | 2023-04-11 | |
| DEF 14A | — | 2023-04-04 | — | |
| DEFA14A | — | 2023-04-04 | — | |
| 8-K | — | 2023-03-13 | 2023-03-10 | |
| 10-Q | — | 2023-02-07 | 2022-12-31 | |
| 8-K | — | 2023-02-07 | — | |
| 10-K/A | — | 2023-01-27 | 2022-09-30 | |
| 8-K | — | 2022-12-02 | 2022-12-01 | |
| 10-K | — | 2022-11-28 | 2022-09-30 | |
| 10-Q | — | 2022-08-09 | 2022-06-30 | |
| 8-K | — | 2022-05-27 | 2022-05-24 | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| DEF 14A | — | 2022-04-11 | — | |
| DEFA14A | — | 2022-04-11 | — | |
| 8-K | — | 2022-04-08 | 2022-04-07 | |
| 8-K | — | 2022-03-04 | — | |
| 10-Q | — | 2022-02-09 | 2021-12-31 | |
| 8-K | — | 2022-02-04 | — | |
| 8-K | — | 2022-02-02 | — | |
| 10-K | — | 2021-11-24 | 2021-09-30 | |
| 8-K | — | 2021-09-27 | — | |
| S-3ASR | — | 2021-09-24 | — | |
| 8-K | — | 2021-09-13 | — | |
| 10-Q | — | 2021-08-12 | 2021-06-30 | |
| 8-K | — | 2021-06-24 | 2021-06-22 | |
| 8-K | — | 2021-05-28 | 2021-05-25 | |
| 10-Q | — | 2021-05-13 | 2021-03-31 | |
| DEF 14A | — | 2021-04-12 | — | |
| PRE 14A | — | 2021-04-01 | — | |
| 10-Q | — | 2021-02-16 | 2020-12-31 | |
| 8-K | — | 2020-12-28 | — | |
| 10-K | — | 2020-12-28 | 2020-09-30 | |
| 8-K | — | 2020-12-15 | — | |
| 8-K | — | 2020-11-06 | — | |
| 8-K | — | 2020-10-15 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-07-02 | 2020-07-01 | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-01 | — |
Showing 51–100 of 104 filings
Key facts
CIK
1314052
CUSIP
032797300
13F (30d)
24 filings
24 filers
Visit website
Investor relations